Kedza, Almansor S.

HRN: 28-69-93  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CEFUROXIME 750MG (VIAL)
03/17/2026
03/24/2026
IV
700mg
Q8H
T/C Acute Bronchitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: